Global Medical Injection Molded Plastics 麻豆原创 Research Report 2025

Publication ID:

PB503252549

Publication Date:

March 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Medical Injection Molded Plastics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Plastic injection molding is听an efficient and cost-effective method of producing medical and pharmaceutical parts to high levels of precision, accuracy, and quality. It is used to create components from medical devices and equipment to laboratory tools and testing instruments.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Injection Molded Plastics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Injection Molded Plastics.
The Medical Injection Molded Plastics market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Injection Molded Plastics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Injection Molded Plastics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Dow, Inc.
SABIC
Eastman Chemical Company
Celanese Corporation
Covestro AG
Rutland Plastic
Evonik Industries AG
Sumitomo Chemical Co., Ltd.
Arkema
INEOS Group
by Type
Polypropylene (PP)
Acrylonitrile Butadiene Styrene (ABS)
Polyethylene (PE)
Polystyrene (PS)
Polycarbonate (PC)
Others
by Application
Medical Components
Implants
Cleanroom Supplies
Mobility Aids
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Injection Molded Plastics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Medical Injection Molded Plastics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Medical Injection Molded Plastics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Medical Injection Molded Plastics 麻豆原创 Overview
1.1 Product Definition
1.2 Medical Injection Molded Plastics by Type
1.2.1 Global Medical Injection Molded Plastics 麻豆原创 Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Polypropylene (PP)
1.2.3 Acrylonitrile Butadiene Styrene (ABS)
1.2.4 Polyethylene (PE)
1.2.5 Polystyrene (PS)
1.2.6 Polycarbonate (PC)
1.2.7 Others
1.3 Medical Injection Molded Plastics by Application
1.3.1 Global Medical Injection Molded Plastics 麻豆原创 Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Medical Components
1.3.3 Implants
1.3.4 Cleanroom Supplies
1.3.5 Mobility Aids
1.3.6 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Medical Injection Molded Plastics Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Medical Injection Molded Plastics Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Medical Injection Molded Plastics Production Estimates and Forecasts (2020-2031)
1.4.4 Global Medical Injection Molded Plastics 麻豆原创 Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Medical Injection Molded Plastics Production 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Medical Injection Molded Plastics Production Value 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Key Players of Medical Injection Molded Plastics, Industry Ranking, 2023 VS 2024
2.4 Global Medical Injection Molded Plastics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Medical Injection Molded Plastics Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Medical Injection Molded Plastics, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Medical Injection Molded Plastics, Product Offered and Application
2.8 Global Key Manufacturers of Medical Injection Molded Plastics, Date of Enter into This Industry
2.9 Medical Injection Molded Plastics 麻豆原创 Competitive Situation and Trends
2.9.1 Medical Injection Molded Plastics 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Medical Injection Molded Plastics Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Medical Injection Molded Plastics Production by Region
3.1 Global Medical Injection Molded Plastics Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Medical Injection Molded Plastics Production Value by Region (2020-2031)
3.2.1 Global Medical Injection Molded Plastics Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Medical Injection Molded Plastics by Region (2026-2031)
3.3 Global Medical Injection Molded Plastics Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Medical Injection Molded Plastics Production Volume by Region (2020-2031)
3.4.1 Global Medical Injection Molded Plastics Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Medical Injection Molded Plastics by Region (2026-2031)
3.5 Global Medical Injection Molded Plastics 麻豆原创 Price Analysis by Region (2020-2025)
3.6 Global Medical Injection Molded Plastics Production and Value, Year-over-Year Growth
3.6.1 North America Medical Injection Molded Plastics Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Medical Injection Molded Plastics Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Medical Injection Molded Plastics Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Medical Injection Molded Plastics Production Value Estimates and Forecasts (2020-2031)
4 Medical Injection Molded Plastics Consumption by Region
4.1 Global Medical Injection Molded Plastics Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Medical Injection Molded Plastics Consumption by Region (2020-2031)
4.2.1 Global Medical Injection Molded Plastics Consumption by Region (2020-2025)
4.2.2 Global Medical Injection Molded Plastics Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Medical Injection Molded Plastics Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Medical Injection Molded Plastics Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Medical Injection Molded Plastics Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Medical Injection Molded Plastics Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Medical Injection Molded Plastics Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Medical Injection Molded Plastics Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Medical Injection Molded Plastics Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Medical Injection Molded Plastics Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Medical Injection Molded Plastics Production by Type (2020-2031)
5.1.1 Global Medical Injection Molded Plastics Production by Type (2020-2025)
5.1.2 Global Medical Injection Molded Plastics Production by Type (2026-2031)
5.1.3 Global Medical Injection Molded Plastics Production 麻豆原创 Share by Type (2020-2031)
5.2 Global Medical Injection Molded Plastics Production Value by Type (2020-2031)
5.2.1 Global Medical Injection Molded Plastics Production Value by Type (2020-2025)
5.2.2 Global Medical Injection Molded Plastics Production Value by Type (2026-2031)
5.2.3 Global Medical Injection Molded Plastics Production Value 麻豆原创 Share by Type (2020-2031)
5.3 Global Medical Injection Molded Plastics Price by Type (2020-2031)
6 Segment by Application
6.1 Global Medical Injection Molded Plastics Production by Application (2020-2031)
6.1.1 Global Medical Injection Molded Plastics Production by Application (2020-2025)
6.1.2 Global Medical Injection Molded Plastics Production by Application (2026-2031)
6.1.3 Global Medical Injection Molded Plastics Production 麻豆原创 Share by Application (2020-2031)
6.2 Global Medical Injection Molded Plastics Production Value by Application (2020-2031)
6.2.1 Global Medical Injection Molded Plastics Production Value by Application (2020-2025)
6.2.2 Global Medical Injection Molded Plastics Production Value by Application (2026-2031)
6.2.3 Global Medical Injection Molded Plastics Production Value 麻豆原创 Share by Application (2020-2031)
6.3 Global Medical Injection Molded Plastics Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Dow, Inc.
7.1.1 Dow, Inc. Medical Injection Molded Plastics Company Information
7.1.2 Dow, Inc. Medical Injection Molded Plastics Product Portfolio
7.1.3 Dow, Inc. Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Dow, Inc. Main Business and 麻豆原创s Served
7.1.5 Dow, Inc. Recent Developments/Updates
7.2 SABIC
7.2.1 SABIC Medical Injection Molded Plastics Company Information
7.2.2 SABIC Medical Injection Molded Plastics Product Portfolio
7.2.3 SABIC Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.2.4 SABIC Main Business and 麻豆原创s Served
7.2.5 SABIC Recent Developments/Updates
7.3 Eastman Chemical Company
7.3.1 Eastman Chemical Company Medical Injection Molded Plastics Company Information
7.3.2 Eastman Chemical Company Medical Injection Molded Plastics Product Portfolio
7.3.3 Eastman Chemical Company Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Eastman Chemical Company Main Business and 麻豆原创s Served
7.3.5 Eastman Chemical Company Recent Developments/Updates
7.4 Celanese Corporation
7.4.1 Celanese Corporation Medical Injection Molded Plastics Company Information
7.4.2 Celanese Corporation Medical Injection Molded Plastics Product Portfolio
7.4.3 Celanese Corporation Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Celanese Corporation Main Business and 麻豆原创s Served
7.4.5 Celanese Corporation Recent Developments/Updates
7.5 Covestro AG
7.5.1 Covestro AG Medical Injection Molded Plastics Company Information
7.5.2 Covestro AG Medical Injection Molded Plastics Product Portfolio
7.5.3 Covestro AG Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Covestro AG Main Business and 麻豆原创s Served
7.5.5 Covestro AG Recent Developments/Updates
7.6 Rutland Plastic
7.6.1 Rutland Plastic Medical Injection Molded Plastics Company Information
7.6.2 Rutland Plastic Medical Injection Molded Plastics Product Portfolio
7.6.3 Rutland Plastic Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Rutland Plastic Main Business and 麻豆原创s Served
7.6.5 Rutland Plastic Recent Developments/Updates
7.7 Evonik Industries AG
7.7.1 Evonik Industries AG Medical Injection Molded Plastics Company Information
7.7.2 Evonik Industries AG Medical Injection Molded Plastics Product Portfolio
7.7.3 Evonik Industries AG Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Evonik Industries AG Main Business and 麻豆原创s Served
7.7.5 Evonik Industries AG Recent Developments/Updates
7.8 Sumitomo Chemical Co., Ltd.
7.8.1 Sumitomo Chemical Co., Ltd. Medical Injection Molded Plastics Company Information
7.8.2 Sumitomo Chemical Co., Ltd. Medical Injection Molded Plastics Product Portfolio
7.8.3 Sumitomo Chemical Co., Ltd. Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Sumitomo Chemical Co., Ltd. Main Business and 麻豆原创s Served
7.8.5 Sumitomo Chemical Co., Ltd. Recent Developments/Updates
7.9 Arkema
7.9.1 Arkema Medical Injection Molded Plastics Company Information
7.9.2 Arkema Medical Injection Molded Plastics Product Portfolio
7.9.3 Arkema Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Arkema Main Business and 麻豆原创s Served
7.9.5 Arkema Recent Developments/Updates
7.10 INEOS Group
7.10.1 INEOS Group Medical Injection Molded Plastics Company Information
7.10.2 INEOS Group Medical Injection Molded Plastics Product Portfolio
7.10.3 INEOS Group Medical Injection Molded Plastics Production, Value, Price and Gross Margin (2020-2025)
7.10.4 INEOS Group Main Business and 麻豆原创s Served
7.10.5 INEOS Group Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Medical Injection Molded Plastics Industry Chain Analysis
8.2 Medical Injection Molded Plastics Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Medical Injection Molded Plastics Production Mode & Process Analysis
8.4 Medical Injection Molded Plastics Sales and 麻豆原创ing
8.4.1 Medical Injection Molded Plastics Sales Channels
8.4.2 Medical Injection Molded Plastics Distributors
8.5 Medical Injection Molded Plastics Customer Analysis
9 Medical Injection Molded Plastics 麻豆原创 Dynamics
9.1 Medical Injection Molded Plastics Industry Trends
9.2 Medical Injection Molded Plastics 麻豆原创 Drivers
9.3 Medical Injection Molded Plastics 麻豆原创 Challenges
9.4 Medical Injection Molded Plastics 麻豆原创 Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Dow, Inc.
SABIC
Eastman Chemical Company
Celanese Corporation
Covestro AG
Rutland Plastic
Evonik Industries AG
Sumitomo Chemical Co., Ltd.
Arkema
INEOS Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.